Pegcetacoplan

ATC L04AJ03 · 6 markets · 12 records

Pegcetacoplan 6 markets · 12 records Forms

AU 5 records · 4 strengths

  • 1,080 mg/20 mLinjectionEmpaveli also in US·GB
  • 1,080 mginjectionEMPAVELI pegcetacoplan 1080 mg/20 mL injection solution vial also in ES unknown
  • 15 mginjectionSYFOVRE pegcetacoplan 15 mg/0.1 mL solution for injection vial unknown

Records without a stated strength · 1 Empaveli、Syfovre

US 2 records · 2 strengths

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 ASPAVELI、Syfovre

    GB 1 records · 1 strengths

    • 1,080 mg/20 mLinjectionAspaveli 1080mg/20ml solution for infusion vials also in AU·US

    CA 1 records · 1 strengths

    ES 1 records · 1 strengths

    Side-by-side table

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.